Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$398M |
| 2 |
Apple
AAPL
|
+$326M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$286M |
| 4 |
UnitedHealth
UNH
|
+$267M |
| 5 |
Veralto
VLTO
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$730M |
| 2 |
Meta Platforms (Facebook)
META
|
+$674M |
| 3 |
Costco
COST
|
+$635M |
| 4 |
Amazon
AMZN
|
+$528M |
| 5 |
Expedia Group
EXPE
|
+$491M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29% |
| 2 | Healthcare | 13.85% |
| 3 | Consumer Discretionary | 11.46% |
| 4 | Financials | 11.04% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Silicon Laboratories
SLAB
$7.17B
| $2.78M | ﹤0.01% |
22,330
-6,863
| -24% | -$751K |
|
1052
Polaris
PII
$4.25B
| $2.77M | ﹤0.01% |
+30,760
| New | +$2.82M |
|
1053
Indivior Pharmaceuticals
INDV
$4.73B
| $2.72M | ﹤0.01% |
176,621
+37,741
| +27% | +$670K |
|
|
SKE
1054
Skeena Resources
SKE
$3.37B
| $2.7M | ﹤0.01% |
632,700
+25,000
| +4% | +$105K |
|
1055
ASML
ASML
$636B
| $2.69M | ﹤0.01% |
3,759
+915
| +32% | +$604K |
|
1056
Reinsurance Group of America
RGA
$15.7B
| $2.69M | ﹤0.01% |
16,365
+16,326
| +41,862% | +$2.54M |
|
1057
Phillips Edison & Co
PECO
$5.46B
| $2.68M | ﹤0.01% |
74,861
-13,081
| -15% | -$458K |
|
1058
Essential Properties Realty Trust
EPRT
$6.9B
| $2.68M | ﹤0.01% |
101,855
-15,503
| -13% | -$359K |
|
1059
Grocery Outlet
GO
$932M
| $2.67M | ﹤0.01% |
99,621
+96,699
| +3,309% | +$2.71M |
|
1060
Liberty Live Group Series A
LLYVA
$9.09B
| $2.65M | ﹤0.01% |
74,786
+73,949
| +8,835% | +$2.45M |
|
1061
VanEck Junior Gold Miners ETF
GDXJ
$7.15B
| $2.65M | ﹤0.01% |
75,000
| – | – |
|
1062
Antero Resources
AR
$10.5B
| $2.65M | ﹤0.01% |
113,019
+160
| +0.1% | +$4.05K |
|
1063
Nexstar Media Group
NXST
$5.67B
| $2.64M | ﹤0.01% |
15,320
+108
| +0.7% | +$15.8K |
|
1064
Eagle Materials
EXP
$6.69B
| $2.64M | ﹤0.01% |
12,963
+4,333
| +50% | +$762K |
|
|
CMA
1065
DELISTED
Comerica
CMA
| $2.63M | ﹤0.01% |
46,815
-279,737
| -86% | -$12.6M |
|
1066
Globus Medical
GMED
$10.6B
| $2.6M | ﹤0.01% |
48,230
-37,822
| -44% | -$1.84M |
|
1067
iShares MSCI Australia ETF
EWA
$1.37B
| $2.58M | ﹤0.01% |
108,900
-33,500
| -24% | -$742K |
|
1068
Emcor
EME
$33B
| $2.58M | ﹤0.01% |
12,039
+7,024
| +140% | +$1.47M |
|
|
HFRO
1069
Highland Opportunities and Income Fund
HFRO
$403M
| $2.57M | ﹤0.01% |
367,181
| – | – |
|
1070
Avis
CAR
$5.78B
| $2.54M | ﹤0.01% |
14,923
-10,336
| -41% | -$1.88M |
|
1071
Iridium Communications
IRDM
$4.87B
| $2.5M | ﹤0.01% |
64,172
+3,997
| +7% | +$158K |
|
1072
TD Synnex
SNX
$19.6B
| $2.49M | ﹤0.01% |
23,689
+23,312
| +6,184% | +$2.29M |
|
|
ETRN
1073
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $2.48M | ﹤0.01% |
231,145
-343,754
| -60% | -$3.23M |
|
1074
Ziff Davis
ZD
$1.93B
| $2.48M | ﹤0.01% |
37,845
-10,706
| -22% | -$679K |
|
1075
Madison Square Garden
MSGS
$9.57B
| $2.47M | ﹤0.01% |
13,830
+10,619
| +331% | +$1.84M |
|
Similar funds
Amundi's Q4 2023 Portfolio in Review
As of Q4 2023, Amundi held 2,118 positions worth $222B, up 9.2% from $203B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Amundi's Q4 2023 filing shows 107 new, 857 increased, 762 reduced and 120 closed positions. Its largest new stake was Veralto: 3,549,374 shares worth $276M. The largest sale was Wells Fargo 7.5% Non Cumv Perp Conv, an estimated $730M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Amundi's largest Q4 2023 buy was Veralto: 3,549,374 shares worth $276M.
- Amundi added most to Johnson & Johnson in Q4 2023, an estimated $398M increase.
- Amundi's biggest Q4 2023 reduction was Wells Fargo 7.5% Non Cumv Perp Conv, cutting an estimated $730M.
- Amundi fully exited Activision Blizzard in Q4 2023, selling an estimated $284M.
- Amundi's ten largest holdings make up 23% of its $222B portfolio in Q4 2023.
- Amundi opened 107 new positions and closed 120 in Q4 2023.
- Amundi's portfolio value rose 9.2% quarter-over-quarter to $222B.
Based on Amundi's 13F filing for Q4 2023, filed 14 Feb 2024.